Zymeworks (ZYME) Misses Q4 EPS by 55c

Zymeworks (NASDAQ: ZYME) reported Q4 EPS of ($0.55). Revenue for the quarter came in at $2.52 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
• Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight